|
|
Article: Newly licensed smallpox vaccine to replace old smallpox vaccine.(Notice to Readers)
- Article from:
- MMWR. Morbidity and Mortality Weekly Report
- Article date:
- February 29, 2008
CopyrightCOPYRIGHT 2008 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CDC has begun distribution of a new-generation smallpox vaccine, ACAM2000[TM] (Acambis, Inc., Cambridge, Massachusetts), to civilian laboratory personnel, the military, and state public health preparedness programs. ACAM2000 is a live, vaccinia virus smallpox vaccine that was licensed for use in the United States by the Food and Drug Administration in August 2007 (1).* ACAM2000 will be replacing Dryvax[R] smallpox vaccine (Wyeth Pharmaceuticals, Inc., Marietta, Pennsylvania) because of withdrawal of the Dryvax license. ACAM2000 is a live vaccinia virus derived from plaque purification cloning from Dryvax. The safety data available from the ACAM2000 clinical trials indicate ...